Hepatitis C prevention and treatment for substance users in the United States: acknowledging the elephant in the living room
- 30 April 2004
- journal article
- editorial
- Published by Elsevier in International Journal of Drug Policy
- Vol. 15 (2) , 81-91
- https://doi.org/10.1016/j.drugpo.2003.10.007
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001
- Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?New England Journal of Medicine, 2001
- Hepatitis C Virus Infection and Needle Exchange Use Among Young Injection Drug Users in San FranciscoHepatology, 2001
- Hepatitis C Virus Infection: Prevalence, Risk Factors, and Prevention Opportunities among Young Injection Drug Users in Chicago, 1997–1999The Journal of Infectious Diseases, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Caring for “Socially Undesirable” PatientsCambridge Quarterly of Healthcare Ethics, 1996
- Treatment services in two national studies of community-based drug abuse treatment programsJournal of Substance Abuse, 1995
- Effectiveness of Reducing Needle-Related Risks for HIV Through Indigenous Outreach to Injection Drug UsersThe American Journal on Addictions, 1992
- Physicians' Reactions to PatientsNew England Journal of Medicine, 1983
- Taking Care of the Hateful PatientNew England Journal of Medicine, 1978